Veerhealth Care Limited (BOM:511523)
India · Delayed Price · Currency is INR 51.42
+2.44 (4.98%)
At close: Nov 9, 2026
Veerhealth Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,028 | 403 | 245 | 415 | 200 | 79 | |
Market Cap Growth | 189.53% | 64.54% | -41.01% | 106.98% | 152.95% | 50.40% |
Enterprise Value | 1,069 | 447 | 237 | 403 | 196 | 77 |
Last Close Price | 51.42 | 20.14 | 12.24 | 20.75 | 10.03 | 5.71 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 68.95 | 74.03 | 62.54 | 102.18 | 12.67 | - |
PS Ratio | 1.93 | 1.24 | 1.45 | 2.92 | 1.41 | 0.73 |
PB Ratio | 4.49 | 1.76 | 1.10 | 1.90 | 0.94 | 0.57 |
P/TBV Ratio | 4.49 | 1.76 | 1.10 | 1.90 | 0.94 | 0.57 |
P/FCF Ratio | - | - | - | 20.05 | - | 35.21 |
P/OCF Ratio | 24.54 | 9.61 | 5.42 | 14.33 | - | 4.38 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.01 | 1.38 | 1.40 | 2.84 | 1.38 | 0.71 |
EV/EBITDA Ratio | 22.61 | 17.19 | 26.52 | 25.22 | 13.62 | 21.83 |
EV/EBIT Ratio | 31.98 | 34.17 | - | 45.43 | 23.98 | - |
EV/FCF Ratio | - | - | - | 19.49 | - | 34.20 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.20 | 0.20 | 0.22 | - | - | - |
Debt / EBITDA Ratio | 0.97 | 1.76 | 5.50 | - | - | - |
Net Debt / Equity Ratio | 0.18 | 0.18 | 0.17 | -0.01 | -0.17 | -0.03 |
Net Debt / EBITDA Ratio | 0.87 | 1.58 | 4.19 | -0.15 | -2.51 | -1.14 |
Net Debt / FCF Ratio | - | -6.20 | -0.87 | -0.11 | 1.30 | -1.79 |
Asset Turnover | - | 0.83 | 0.55 | 0.53 | 0.63 | 0.56 |
Inventory Turnover | - | 7.06 | 6.03 | 4.63 | 4.01 | 3.76 |
Quick Ratio | - | 0.76 | 0.60 | 1.50 | 5.59 | 0.79 |
Current Ratio | - | 1.37 | 2.43 | 4.85 | 10.62 | 2.53 |
Return on Equity (ROE) | - | 2.41% | 1.78% | 1.88% | 8.94% | -0.53% |
Return on Assets (ROA) | - | 2.10% | -0.03% | 2.08% | 2.25% | -0.55% |
Return on Invested Capital (ROIC) | 7.59% | 2.14% | -0.04% | 1.43% | 5.21% | 0.36% |
Return on Capital Employed (ROCE) | - | 4.30% | 0.00% | 3.50% | 3.40% | -1.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.45% | 1.35% | 1.60% | 0.98% | 7.89% | -0.93% |
FCF Yield | -0.65% | -1.65% | -17.56% | 4.99% | -13.89% | 2.84% |
Buyback Yield / Dilution | -5.08% | - | - | - | -44.20% | - |